Vaxil Bio (TSXV:VXL) Cyclically Adjusted Book per Share: C$0.40 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:VXL Vaxil Bio Ltd TSXV:VXL
38 GF Score
Price C$0.16
! 2 Warning Signs
View Full Analysis

What is Vaxil Bio Cyclically Adjusted Book per Share?

Vaxil Bio TSXV:VXL 38 Cyclically Adjusted Book per Share is C$0.40 as of Mar. 2026. GuruFocus rates TSXV:VXL with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Vaxil Bio's adjusted book value per share for the three months ended in Mar. 2026 was C$0.316. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$0.40 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vaxil Bio's average Cyclically Adjusted Book Growth Rate was -8.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -33.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -42.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Vaxil Bio was -33.00% per year. The lowest was -51.90% per year. And the median was -47.80% per year.

As of today (2026-07-20), Vaxil Bio's current stock price is C$0.155. Vaxil Bio's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was C$0.40. Vaxil Bio's Cyclically Adjusted PB Ratio of today is 0.39.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vaxil Bio was 0.39. The lowest was 0.00. And the median was 0.00.


Vaxil Bio  (TSXV:VXL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vaxil Bio's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.155/0.40
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vaxil Bio was 0.39. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Vaxil Bio Cyclically Adjusted Book per Share Related Terms


Vaxil Bio Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Vaxil Bio's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxil Bio Cyclically Adjusted Book per Share Chart

Vaxil Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.86 1.46 0.79 0.48 0.44

Vaxil Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.40 0.41 0.44 0.40

TSXV:VXL vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Vaxil Bio's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxil Bio Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's Cyclically Adjusted PB Ratio falls into.


TSXV:VXL
38GF Score
Vaxil Bio Ltd TSXV:VXL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxil Bio Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vaxil Bio's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.316/132.2623*132.2623
=0.316

Current CPI (Mar. 2026) = 132.2623.

Vaxil Bio Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.590 102.002 2.062
201609 1.281 101.765 1.665
201612 0.686 101.449 0.894
201703 0.649 102.634 0.836
201706 0.285 103.029 0.366
201709 -1.529 103.345 -1.957
201712 -0.481 103.345 -0.616
201803 0.535 105.004 0.674
201806 0.480 105.557 0.601
201809 0.442 105.636 0.553
201812 0.245 105.399 0.307
201903 0.126 106.979 0.156
201906 0.035 107.690 0.043
201909 -0.066 107.611 -0.081
201912 -0.328 107.769 -0.403
202003 0.184 107.927 0.225
202006 0.200 108.401 0.244
202009 0.096 108.164 0.117
202012 0.338 108.559 0.412
202103 0.870 110.298 1.043
202106 0.796 111.720 0.942
202109 0.711 112.905 0.833
202112 0.620 113.774 0.721
202203 0.575 117.646 0.646
202206 0.523 120.806 0.573
202209 0.475 120.648 0.521
202212 0.415 120.964 0.454
202303 0.369 122.702 0.398
202306 0.324 124.203 0.345
202309 0.314 125.230 0.332
202312 0.325 125.072 0.344
202403 0.305 126.258 0.320
202406 0.287 127.522 0.298
202409 0.269 127.285 0.280
202412 0.261 127.364 0.271
202503 0.235 129.181 0.241
202506 0.252 129.892 0.257
202509 0.243 130.287 0.247
202512 0.343 130.366 0.348
202603 0.316 132.262 0.316

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of C$0.40 mean?
Vaxil Bio (TSXV:VXL) has a Cyclically Adjusted Book per Share of C$0.40 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vaxil Bio and its competitors.
Is Vaxil Bio's Cyclically Adjusted Book per Share too high?
Vaxil Bio's current Cyclically Adjusted Book per Share is C$0.40. Overall, Vaxil Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Vaxil Bio's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Vaxil Bio's Cyclically Adjusted Book per Share of C$0.40 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vaxil Bio and its competitors. Vaxil Bio's current Cyclically Adjusted Book per Share is C$0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxil Bio stock overvalued right now?
Vaxil Bio (TSXV:VXL) has a current Cyclically Adjusted Book per Share of C$0.40. The current Cyclically Adjusted Book per Share is C$0.40. Vaxil Bio's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Vaxil Bio (TSXV:VXL), the current Cyclically Adjusted Book per Share is C$0.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxil Bio Business Description

Other Exchanges VXLLF:USA
Address 559 Briar Hill Avenue, Toronto, ON, CAN, M5N 1N1
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
38GF Score

Get the complete analysis for TSXV:VXL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.16
Price